STEMRIM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 457 JPY | -2.35% |
|
-2.77% | -20.93% |
| 05-09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
| 03-13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| STEMRIM | Biopharmaceuticals | -2.35% | -2.77% | -20.93% | -61.43% | - | 185M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4599 Stock
- Charts StemRIM
- Comparison Chart